Cargando…
New pharmacotherapy options for noninfectious posterior uveitis
INTRODUCTION: Noninfectious inflammation of the posterior eye segment represents an important cause of visual impairment. It often affects relatively young people and causes a significant personal and social impact. Although steroids and nonbiologic- Disease-Modifying Antirheumatic Drugs (nbDMARDs)...
Autores principales: | Pleyer, Uwe, Neri, Piergiorgio, Deuter, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172489/ https://www.ncbi.nlm.nih.gov/pubmed/33634341 http://dx.doi.org/10.1007/s10792-021-01763-8 |
Ejemplares similares
-
Dexamethasone implants in paediatric patients with noninfectious intermediate or posterior uveitis: first prospective exploratory case series
por: Winterhalter, Sibylle, et al.
Publicado: (2017) -
Management of noninfectious posterior uveitis with intravitreal drug therapy
por: Tan, Hui Yi, et al.
Publicado: (2016) -
Intraocular therapy in noninfectious uveitis
por: Modugno, Rocco Luigi, et al.
Publicado: (2021) -
Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant
por: Myung, Jane S, et al.
Publicado: (2010) -
Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis
por: Tufail, Adnan, et al.
Publicado: (2018)